Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 0.98 | 1.03 | 0.94 | 0.83 |
Depreciation/ Depletion | 0.66 | 0.63 | 0.56 | 0.06 |
Non- Cash Items | -0.04 | -0.61 | -0.18 | -0.27 |
Changesin Working Capital | -8.69 | 3.17 | -9.05 | -1.45 |
Cashfrom Operating Activities | -7.08 | 4.22 | -7.73 | -0.83 |
Capital Expenditures | -0.35 | -0.22 | -0.15 | 0.00 |
Other Investing Cash Flow Items Total | -0.20 | 2.22 | 0.75 | -2.94 |
Cashfrom Investing Activities | -0.55 | 2.00 | 0.59 | -2.94 |
Financing Cash Flow Items | -0.14 | -0.15 | -0.46 | -0.09 |
Issuance( Retirement)of Stock Net | 20.50 | 0.00 | 0.95 | 6.34 |
Cashfrom Financing Activities | 20.36 | -4.70 | 3.28 | 7.81 |
Net Changein Cash | 12.73 | 1.52 | -3.85 | 4.05 |
Cash Interest Paid | 0.14 | 0.15 | 0.46 | 0.09 |
Cash Taxes Paid | 0.03 | -0.08 | 0.21 | 0.18 |
Issuance( Retirement)of Debt Net | - | -4.55 | 2.79 | 1.56 |
Eiko Lifesciences Dividend Eiko Lifesciences Bonus Eiko Lifesciences News Eiko Lifesciences AGM Eiko Lifesciences Rights Eiko Lifesciences Splits Eiko Lifesciences Board Meetings Eiko Lifesciences Key Metrics Eiko Lifesciences Shareholdings Eiko Lifesciences Profit Loss Eiko Lifesciences Balance Sheet Eiko Lifesciences Q1 Results Eiko Lifesciences Q2 Results Eiko Lifesciences Q3 Results Eiko Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks